Ledger.Open graph →
SEC Form D · filed December 17, 2021

Tulavi Therapeutics, Inc

Offering
$1.0M
Sold
$1.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
MOUNTAIN VIEW, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Henry Chen · Mountain View, CADirectorSteve Willamson · Mountain View, CADirectorFarhad Khosravi · Mountain View, CADirectorCorinne Bright · Mountain View, CAExec · DirectorTara Butler · Mountain View, CADirectorAmar Sawhney · Mountain View, CADirectorGreg Casciaro · Mountain View, CADirectorDavid Pearah · Lenexa, KSExec · DirectorJ.T. Norville · Saint Louis, MODirectorEric Goettelmann · Saint Louis, MODirectorWon Yang · Galveston, TXDirectorWilliam Conroy · Lenexa, KSDirectorLon Chow · Lenexa, KSDirectorJoseph Corcoran · New York, NYDirectorSamuel Riter · New York, NYExec · DirectorJ.S. White Oak Specialized ABL Partners, LLC · San Francisco, CADirectorKevin Sun · Carbondale, ILDirectorNoah Fulk · Carbondale, ILDirectorChristian A. Diez · New York, NYDirectorGreg Casciaro · Pleasanton, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗